Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. New research suggests that the casirivimab-imdevimab monoclonal antibody treatment for COVID-19 ...

WASHINGTON - The U.S. Food and Drug Administration has cleared a formulation of the COVID-19 antibody drug made by Regeneron Pharmaceuticals Inc. that can be injected, rather than administered by IV ...

The Food and Drug Administration (FDA) has authorized Regeneron’s COVID-19 antibody drug for injections. Regeneron said in a statement on Friday that the agency updated the emergency use authorization ...

A new monoclonal antibody treatment has been found to protect chronically ill adults from developing COVID-19. The Phase 3 trial results suggest the novel antibody cocktail, delivered by intramuscular ...

RALEIGH, N.C. (WTVD) -- Katherine Wall and her whole family got COVID-19 in January before vaccines were readily available. She said she has an underlying autoimmune disease and got really sick. "I ...

Nov 12 (Reuters) - Britain's GSK (GSK.L), opens new tab and partner Vir (VIR.O), opens new tab said on Friday their antibody-based COVID-19 drug was shown in a trial to work as well when given as a ...

FILE PHOTO: The Regeneron Pharmaceuticals company logo is seen on a building at the company's Westchester campus in Tarrytown, New York (Reuters) -The U.S. health regulator authorized a lower dose of ...

Antibody infusions a 'game-changer' in fight against Covid From left, Melissa Edmister, Jesse Arneson and Leah Scaramuzzo at Logan Health Medical Center on Nov. 9, 2021. (Matt Baldwin/Daily Inter Lake ...

When Eli Lilly gained emergency use approval for its COVID-19 antibody treatment last October, it was a major triumph for a company aiming to satisfy a desperate need around the world. But eight ...

(Reuters) -Britain's GSK and partner Vir said on Friday their antibody-based COVID-19 drug was shown in a trial to work as well when given as a shot in the arm awhen administered via the standard ...

Nov 12 (Reuters) - Britain's GSK GSK.L and partner Vir VIR.O said on Friday their antibody-based COVID-19 drug was shown in a trial to work as well when given as a shot in the arm awhen administered ...